Travaux privés

Dossiers économiques globaux

Dossiers globaux ayant pour objectif de soutenir l’accès au marché au niveau mondial, les DEGs synthétisent la recherche clinique et économique, la littérature accessible au public et les stratégies de marché, et présentent une justification rigoureuse des interventions en soins de santé basé sur les données probantes. Nous avons développé ces dossiers pour des produits approuvés ou en développement dans une variété de domaines thérapeutiques …cardiologie, gastroenterologie, maladies infectieuses, neurologie, oncologie, psychiatrie, rhumatologie….

Mallette de soumission aux formulaires

Nous avons préparé plus de 200 soumissions destinées aux décideurs Canadiens et Américains, incluant des résumés d’information de base, des justifications cliniques et économiques, des modèles d’impact budgétaire et rapports, des formulaires spécifiques et des rapports adaptés aux auditoires cibles

Matériel de présentation

Posters, diapositives, documentation à distribuer et autres matériels de présentation pour la dissémination à l’interne ou à l’externe d’information portant sur la recherche évaluative, les activités de recherche et les stratégies (posters, présentations de premier conférencier, présentations orales, matériel pour les salles de conférence et les salles de classe)

Documents d’Information de Base, Documents de Briefing & Rapports (par exemple…)

  • Economic evaluation of vancomycin and fidaxomicin for the treatment of clostridium difficile infection in Canada
  • Literature review and critical analysis of the burden of Varicella infection
  • Literature review and gap analysis of depot antipsychotic medications for schizophrenia and their effect on compliance and outcomes
  • Systematic review of the natural history of HPV infection and associated diseases in females 9-26
  • Systematic literature review on the clinical and economic burden and treatment of heart failure in Canada
  • Gap analysis for diagnostic medical device used for the detection of H. pylori. in Ontario
  • Human Papilloma virus (HPV): homosexual transmission and burden of disease
  • Human Papilloma virus (HPV): heterosexual transmission and burden of disease
  • A common road map for data synthesis, clinical practice guidelines and policymaking—applications of the EVIDEM framework
  • Antithrombotic therapy for prevention of stroke in atrial fibrillation: disease burden and unmet needs
  • Etude de la faisabilité de la mise en place d'une banque de lait maternel chez Héma-Québec
  • Canadian Workplace Health Promotion programs; health and economic outcomes
  • Aspects of workplace disease management and employee health in Canada
  • Global clinical and economic burden of nosocomial infections - with a focus on S aureus and post-surgical infection
  • Health policy study examining the cost of oncology medicines in Canada
  • Literature review on the natural history of human papillomavirus (HPV) infection and associated diseases in men
  • The value of pharmaceutical innovation in Canada
  • The natural history of human papillomavirus (HPV) infection in adult women
  • Epidemiological and etiological aspects of CABP and cSSSi
  • Clinical, pharmacoeconomic and quality of life evidence for direct renin inhibitors, angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors for all indications
  • Systematic review of the biomedical literature on the topic of stable angina, its epidemiology, treatment and burden
  • Comprehensive review of the biomedical literature on the topic of risk of metabolic syndrome in patients treated with the atypical antipsychotics
  • Systematic review of biomedical literature: rotavirus epidemiology and burden of illness in the middle east and Europe
  • Systematic literature review and gap analysis: negative pressure wound healing
  • Comprehensive literature review of opioid-induced constipation: epidemiology, health care utilization, quality of life and clinical
  • Antithrombotic Therapy for Prevention of Stroke in Atrial Fibrillation: Evidence on Disease Burden and Unmet Needs
  • Analysis of sub-optimal coagulation in atrial fibrillation
  • Comprehensive literature review on the burden of disease and unmet needs for prevention and treatment of venous thromboembolism (VTE) in the medically ill
  • The association between anal intraepithelial neoplasia (AIN) and anal cancer
  • Atrial fibrillation patient subgroup analysis
  • Costs of urinary tract infections in Germany, the UK and USA
  • Role of HTA in decisionmaking: report on selected drug policy issues in Canada
  • Aspects of the natural history of human papillomavirus (HPV) infection and associated diseases
  • Systematic literature review on quality of life and ostomy
  • Assessing the future of 'authorized generics' in different market segments - US, UK, France & Japan
  • Renal anemia and EPO - Pre-dialysis renal anemia market
  • Venous leg ulcers (all forms) - patient compliance and impact on clinical and economic outcomes
  • Canadianizing an economic model comparing intensive atorvastatin treatment with standard simvastatin treatment based on data from the CARDS trial
  • Cytomegalovirus (CMV): Biomarkers of congenital infection & disease and relationships therein
  • Vaccination programs for pneumococcal disease in adults (≥50 years): Evidence on disease burden and unmet needs
  • Vaccination programs for pneumococcal disease in the pediatric population: Evidence on disease burden and unmet needs
  • Pneumococcal vaccine development in the post-Prevnar era: key issues in epidemiology and economic modeling
  • Glaucoma (IOP) treatment in Canada
  • HPV Vaccination
  • Hip fracture
  • Reimbursement and J-Code incentives for pharmacological stress test drugs (adenosine, dipyridamole, dobutamine) in the US
  • DPP-4 inhibitors for diabetes
  • Costs of short and long term disability in Type II diabetes, in particular relating to poor glycemic control, from the perspective of 3rd party payers (i.e., insurers, employers)
  • The burden of Major Depressive Disorder (MDD)
  • Health and economic outcome measures (number needed-to-treat and cost per quality adjusted life year) for medical interventions in Canada and the US
  • Osteoarthritis and rheumatoid arthritis in Canada
  • Pharmacoeconomic Assessment of medication for treatment of ulcers and gastroesophageal reflux disease (GERD)
  • Comparison of NSAID + PPI treatment versus COX-2 selective inhibitors on NSAID-related gastrointestinal events
  • Status of Paget's Disease, treatments and current practice in Canada
  • Vitamin D and osteoporosis
  • Marketing of pharmaceutical products in the 1980s and 1990s
  • Sarcopenia and cachexia: burden of illness and management patterns
  • Congestive heart failure (CHF) in Ontario and Quebec
  • Rates of nausea & vomiting and sexual dysfunction with SSRI & SNRI antidepressant use, their impact on compliance, and the effect of compliance on depression outcomes
  • Cost-of-illness of acromegaly and associated co-morbidities
  • Acromegaly and associated comorbidities
  • Haloperidol treatment for schizophrenia
  • Positioning of omalizumab relative to other biologics in Canada
  • Risperidone treatment for schizophrenia
  • Oral inflammation and human systemic disease [Texte intégral]
  • Drivers of health care cost growth in the US
  • The treatment of dyslipidemia
  • The limitations of statin therapy in the treatment of hypercholesterolemia
  • Prostate cancer treatment in Canada: current status and research investment
  • Salmon calcitonin nasal spray (Miacalcin) for osteoporosis
  • Economic and quality of life outcomes in renal and oncology-related anemia
  • The Science Behind Colgate Total
  • Deep vein thrombosis treatment and the market for non-pharmacological approaches
  • Managing escalating pharmaceutical costs: challenges facing pharmacy services
  • Economic evaluation and quality of life in organ transplantation
  • New approaches to therapeutic intervention in cardiac hypertrophy
  • Forces influencing inpatient hospital costs in the United States
  • The role of Triclosan/Copolymer dentifrice in the prevention and control of periodontal disease

 

Information pour le Patient & Matériel de Formation (par exemple…)

= Texte intégral disponible
  • Harvard Continuing Medical Education for Dental Health Professionals
    Préparation de matériel pour la formation continue basé sur la recherche en santé buccale, 1996-présent
  • Manuel de transplantation pulmonaire/Lung transplantation manual
    Mallette d’information pluridisciplinaire destinée aux patients recevant une transplantation pulmonaire
  • Major published clinical trials in the treatment of rheumatoid arthritis and osteoarthritis
    Résumés structurés d'études cliniques en rhumatologie; format multimédia destiné à la formation continue
  • Accreditation course modules
    Révision, évaluation et préparation d'un rapport portant sur 13 modules de formation de base en sciences biomédicales et pharmacologiques destinés au personnel du marketing et des ventes de l'industrie pharmaceutique
  • Biomedical course modules
    Collection de matériel multimédia développée pour la formation de base en sciences biomédicales du personnel de l'industrie pharmaceutique